Division of Cardiothoracic Surgery, Section of General Thoracic Surgery, Department of Surgery, University of Colorado Denver, Aurora, CO, USA.
Division of Surgical Oncology, Department of Surgery, University of Colorado Denver, Aurora, CO, USA.
Surg Endosc. 2020 Aug;34(8):3470-3478. doi: 10.1007/s00464-019-07124-y. Epub 2019 Oct 7.
The objectives were to determine factors associated with conversion to open surgery in patients with esophageal cancer who underwent minimally invasive esophagectomy (MIE, including laparo-thoracoscopic and robotic) and the impact of conversion to open surgery on patient outcomes.
We included patients from the National Cancer Database with esophageal and gastroesophageal junction cancer who underwent MIE from 2010 to 2015. Patient-, tumor-, and facility-related characteristics as well as short-term and oncologic outcomes were compared between patients who were converted to open surgery and those who underwent successful MIE without conversion to open surgery. Multivariable logistic regression models were used to analyze risk factors for conversion to open surgery from attempted MIE.
7306 patients underwent attempted MIE. Of these patients, 82 of 1487 (5.2%) robotic-assisted esophagectomies were converted to open, compared to 691 of 5737 (12.0%) laparo-thoracoscopic esophagectomies (p < 0.001). Conversion rates decreased significantly over the study period (p = 0.010). Patient age, tumor size, and nodal involvement were independently associated with conversion. Facility minimally invasive cumulative volume and robotic approach were associated with decreased conversion rates. Patients whose MIEs were converted had increased 90-day mortality [Odds Ratio (OR) 1.49; 95% Confidence Interval (CI) 1.10, 2.02], prolonged hospital stay (OR 1.39; 95% CI 1.17, 1.66), and higher rates of unplanned readmission (OR 1.67; 95% CI 1.27, 2.20). No significant differences were found in surgical margins or number of lymph nodes harvested.
Patients undergoing attempted MIE requiring conversion to open surgery had significantly worse short-term outcomes including postoperative mortality. Patient factors and hospital experience contribute to conversion rates. These findings should inform surgeons and patients considering esophagectomy for cancer.
确定接受微创食管切除术(MIE,包括腹腔镜-胸腔镜和机器人辅助)的食管癌患者中转开胸手术的相关因素,以及中转开胸手术对患者结局的影响。
我们纳入了 2010 年至 2015 年期间在国家癌症数据库中接受 MIE 的食管癌和胃食管交界处癌患者。比较了成功完成 MIE 而未中转开胸手术的患者与中转开胸手术的患者在患者、肿瘤和医疗机构相关特征以及短期和肿瘤学结局方面的差异。使用多变量逻辑回归模型分析了从尝试 MIE 中转开胸手术的风险因素。
7306 例患者接受了尝试 MIE。其中,1487 例机器人辅助食管切除术中转开胸的患者中有 82 例(5.2%),5737 例腹腔镜-胸腔镜食管切除术中转开胸的患者中有 691 例(12.0%)(p<0.001)。在研究期间,转化率显著下降(p=0.010)。患者年龄、肿瘤大小和淋巴结受累与转化率独立相关。医疗机构微创累积量和机器人方法与转化率降低相关。MIE 中转开胸的患者 90 天死亡率增加(优势比[OR]1.49;95%置信区间[CI]1.10,2.02),住院时间延长(OR 1.39;95%CI 1.17,1.66),计划外再入院率更高(OR 1.67;95%CI 1.27,2.20)。手术切缘和淋巴结采集数量无显著差异。
接受尝试 MIE 但需要中转开胸手术的患者短期结局显著恶化,包括术后死亡率。患者因素和医疗机构经验是转化率的决定因素。这些发现应该为考虑进行癌症食管切除术的外科医生和患者提供信息。